{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:22Z","timestamp":1707524422804},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,3]]},"DOI":"10.7759\/cureus.20134","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T15:36:42Z","timestamp":1638545802000},"source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia"],"prefix":"10.7759","author":[{"given":"Colton","family":"Ladbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandeep","family":"Salhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Dandapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner RA","year":"2017","unstructured":"Gardner RA, Finney O, Annesley C, et al.. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood. 2017, 129:3322-31. 10.1182\/blood-2017-02-769208","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee DW","year":"2015","unstructured":"Lee DW, Kochenderfer JN, Stetler-Stevenson M, et al.. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015, 385:517-28. 10.1016\/S0140-6736(14)61403-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000018","article-title":"Mechanisms of and approaches to overcoming resistance to immunotherapy","volume":"2019","author":"Schultz L","year":"2019","unstructured":"Schultz L, Gardner R. Mechanisms of and approaches to overcoming resistance to immunotherapy. Hematology Am Soc Hematol Educ Program. 2019, 2019:226-32. 10.1182\/hematology.2019000018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28870","article-title":"Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia","volume":"68","author":"Marquez CP","year":"2021","unstructured":"Marquez CP, Montiel-Esparza R, Hui C, et al.. Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021, 68:10.1002\/pbc.28870","journal-title":"Pediatr Blood Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001450","article-title":"Bilateral retinal detachment after chimeric antigen receptor T-cell therapy","volume":"4","author":"Denton CC","year":"2020","unstructured":"Denton CC, Gange WS, Abdel-Azim H, et al.. Bilateral retinal detachment after chimeric antigen receptor T-cell therapy. Blood Adv. 2020, 4:2158-62. 10.1182\/bloodadvances.2020001450","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude SL","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, et al.. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014, 371:1507-17. 10.1056\/NEJMoa1407222","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0184-6","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah NN","year":"2019","unstructured":"Shah NN, Fry TJ. Mechanisms of resistance to CAR T cell therapy. Nat Rev Clin Oncol. 2019, 16:372-85. 10.1038\/s41571-019-0184-6","journal-title":"Nat Rev Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey DT","year":"2016","unstructured":"Teachey DT, Lacey SF, Shaw PA, et al.. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016, 6:664-79. 10.1158\/2159-8290.CD-16-0040","journal-title":"Cancer Discov"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02104","article-title":"Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US lymphoma CAR T consortium","volume":"38","author":"Nastoupil LJ","year":"2020","unstructured":"Nastoupil LJ, Jain MD, Feng L, et al.. Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US lymphoma CAR T consortium. J Clin Oncol. 2020, 38:3119-28. 10.1200\/JCO.19.02104","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag1266","article-title":"The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications","volume":"1","author":"Spiotto M","year":"2016","unstructured":"Spiotto M, Fu YX, Weichselbaum RR. The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications. Sci Immunol. 2016, 1:10.1126\/sciimmunol.aag1266","journal-title":"Sci Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30461-9","article-title":"Enhancing CAR T-cell therapy through cellular imaging and radiotherapy","volume":"20","author":"Minn I","year":"2019","unstructured":"Minn I, Rowe SP, Pomper MG. Enhancing CAR T-cell therapy through cellular imaging and radiotherapy. Lancet Oncol. 2019, 20:443-51. 10.1016\/S1470-2045(19)30461-9","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.09.008","article-title":"Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape","volume":"26","author":"DeSelm C","year":"2018","unstructured":"DeSelm C, Palomba ML, Yahalom J, Hamieh M, Eyquem J, Rajasekhar VK, Sadelain M. Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape. Mol Ther. 2018, 26:2542-52. 10.1016\/j.ymthe.2018.09.008","journal-title":"Mol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1788","article-title":"NKG2D-based CAR T cells and radiotherapy exert synergistic efficacy in glioblastoma","volume":"78","author":"Weiss T","year":"2018","unstructured":"Weiss T, Weller M, Guckenberger M, Sentman CL, Roth P. NKG2D-based CAR T cells and radiotherapy exert synergistic efficacy in glioblastoma. Cancer Res. 2018, 78:1031-43. 10.1158\/0008-5472.CAN-17-1788","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.05.014","article-title":"Bridging radiation therapy before commercial chimeric antigen receptor T-cell therapy for relapsed or refractory aggressive B-cell lymphoma","volume":"108","author":"Wright CM","year":"2020","unstructured":"Wright CM, LaRiviere MJ, Baron JA, et al.. Bridging radiation therapy before commercial chimeric antigen receptor T-cell therapy for relapsed or refractory aggressive B-cell lymphoma. Int J Radiat Oncol Biol Phys. 2020, 108:178-88. 10.1016\/j.ijrobp.2020.05.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001837","article-title":"Bridging therapy prior to axicabtagene ciloleucel for relapsed\/refractory large B-cell lymphoma","volume":"4","author":"Pinnix CC","year":"2020","unstructured":"Pinnix CC, Gunther JR, Dabaja BS, et al.. Bridging therapy prior to axicabtagene ciloleucel for relapsed\/refractory large B-cell lymphoma. Blood Adv. 2020, 4:2871-83. 10.1182\/bloodadvances.2020001837","journal-title":"Blood Adv"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.05.065","article-title":"Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma","volume":"105","author":"Sim AJ","year":"2019","unstructured":"Sim AJ, Jain MD, Figura NB, et al.. Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys. 2019, 105:1012-21. 10.1016\/j.ijrobp.2019.05.065","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002346","article-title":"Navigating the narrow bridge to CAR T-cell therapy","volume":"4","author":"Yang JC","year":"2020","unstructured":"Yang JC, Plastaras JP. Navigating the narrow bridge to CAR T-cell therapy. Blood Adv. 2020, 4:2884-5. 10.1182\/bloodadvances.2020002346","journal-title":"Blood Adv"},{"key":"ref18","article-title":"Is the testis a chemo-privileged site? Is there a blood-testis barrier?","volume":"9","author":"Dave DS","year":"2007","unstructured":"Dave DS, Leppert JT, Rajfer J. Is the testis a chemo-privileged site? Is there a blood-testis barrier?. Rev Urol. 2007, 9:28-32.","journal-title":"Rev Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33609","article-title":"Testicular involvement of acute lymphoblastic leukemia in children and adolescents: diagnosis, biology, and management","volume":"127","author":"Nguyen HT","year":"2021","unstructured":"Nguyen HT, Terao MA, Green DM, Pui CH, Inaba H. Testicular involvement of acute lymphoblastic leukemia in children and adolescents: diagnosis, biology, and management. Cancer. 2021, 127:3067-81. 10.1002\/cncr.33609","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/adc.58.2.128","article-title":"Isolated testicular relapse in acute lymphoblastic leukaemia of childhood. Report on behalf of the Medical Research Council's working party on leukaemia in childhood","volume":"58","author":"Eden OB","year":"1983","unstructured":"Eden OB, Rankin A, Kay HE. Isolated testicular relapse in acute lymphoblastic leukaemia of childhood. Report on behalf of the Medical Research Council's working party on leukaemia in childhood. Arch Dis Child. 1983, 58:128-32. 10.1136\/adc.58.2.128","journal-title":"Arch Dis Child"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.11.005","article-title":"KMT2A rearranged acute lymphoblastic leukaemia: unravelling the genomic complexity and heterogeneity of this high-risk disease","volume":"469","author":"Forgione MO","year":"2020","unstructured":"Forgione MO, McClure BJ, Eadie LN, Yeung DT, White DL. KMT2A rearranged acute lymphoblastic leukaemia: unravelling the genomic complexity and heterogeneity of this high-risk disease. Cancer Lett. 2020, 469:410-8. 10.1016\/j.canlet.2019.11.005","journal-title":"Cancer Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78425-adjuvant-scrotal-radiation-therapy-as-bridging-therapy-to-chimeric-antigen-receptor-t-cell-following-extramedullary-relapse-in-b-cell-acute-lymphoblastic-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:31Z","timestamp":1707507151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78425-adjuvant-scrotal-radiation-therapy-as-bridging-therapy-to-chimeric-antigen-receptor-t-cell-following-extramedullary-relapse-in-b-cell-acute-lymphoblastic-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.20134","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,3]]}}}